Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$145.48 - $175.02 $165,265 - $198,822
1,136 Added 10.37%
12,086 $2.01 Million
Q4 2022

Jan 25, 2023

SELL
$131.14 - $157.47 $27,670 - $33,226
-211 Reduced 1.89%
10,950 $1.6 Million
Q3 2022

Oct 31, 2022

SELL
$148.29 - $182.55 $13,197 - $16,246
-89 Reduced 0.79%
11,161 $1.66 Million
Q2 2022

Jul 26, 2022

SELL
$155.97 - $200.09 $53,809 - $69,031
-345 Reduced 2.98%
11,250 $1.93 Million
Q1 2022

Apr 21, 2022

SELL
$181.39 - $234.03 $928,898 - $1.2 Million
-5,121 Reduced 30.64%
11,595 $2.19 Million
Q4 2021

Feb 02, 2022

SELL
$193.69 - $247.03 $3,680 - $4,693
-19 Reduced 0.11%
16,716 $4.08 Million
Q3 2021

Nov 04, 2021

SELL
$189.29 - $209.69 $288,099 - $319,148
-1,522 Reduced 8.34%
16,735 $3.25 Million
Q2 2021

Jul 29, 2021

BUY
$155.9 - $187.99 $29,776 - $35,906
191 Added 1.06%
18,257 $3.4 Million
Q1 2021

May 06, 2021

SELL
$144.0 - $169.39 $63,792 - $75,039
-443 Reduced 2.39%
18,066 $2.85 Million
Q4 2020

Feb 02, 2021

SELL
$157.07 - $174.35 $1.24 Million - $1.38 Million
-7,904 Reduced 29.92%
18,509 $3.06 Million
Q3 2020

Nov 03, 2020

SELL
$137.1 - $165.37 $248,699 - $299,981
-1,814 Reduced 6.43%
26,413 $4.37 Million
Q2 2020

Aug 05, 2020

SELL
$111.92 - $142.53 $450,589 - $573,825
-4,026 Reduced 12.48%
28,227 $3.87 Million
Q1 2020

May 08, 2020

SELL
$92.66 - $144.94 $75,054 - $117,401
-810 Reduced 2.45%
32,253 $3.8 Million
Q4 2019

Feb 06, 2020

SELL
$116.25 - $133.25 $508,477 - $582,835
-4,374 Reduced 11.68%
33,063 $4.38 Million
Q3 2019

Oct 29, 2019

SELL
$112.57 - $128.43 $2.12 Million - $2.42 Million
-18,839 Reduced 33.48%
37,437 $4.66 Million
Q2 2019

Aug 07, 2019

SELL
$97.98 - $114.28 $130,607 - $152,335
-1,333 Reduced 2.31%
56,276 $6.39 Million
Q1 2019

May 03, 2019

SELL
$81.56 - $100.67 $79,521 - $98,153
-975 Reduced 1.66%
57,609 $5.8 Million
Q4 2018

Feb 04, 2019

SELL
$79.28 - $95.27 $186,625 - $224,265
-2,354 Reduced 3.86%
58,584 $5.01 Million
Q3 2018

Nov 01, 2018

SELL
$83.5 - $93.23 $132,598 - $148,049
-1,588 Reduced 2.54%
60,938 $5.58 Million
Q2 2018

Aug 07, 2018

SELL
$79.9 - $89.2 $457,827 - $511,116
-5,730 Reduced 8.39%
62,526 $5.33 Million
Q1 2018

May 07, 2018

SELL
$71.51 - $84.69 $67,147 - $79,523
-939 Reduced 1.36%
68,256 $5.7 Million
Q4 2017

Feb 05, 2018

SELL
$63.24 - $72.8 $194,463 - $223,860
-3,075 Reduced 4.25%
69,195 $4.98 Million
Q3 2017

Nov 03, 2017

BUY
$59.73 - $65.4 $4.32 Million - $4.73 Million
72,270
72,270 $4.61 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.